Quick Search

 

 


 

 

Result Summary for 25000/574

Result Summary
Protocol ID: 25000/574
Clinical Study ID: 574
Official Title: A study to determine the pharmacokinetic profiles of amoxicillin and clavulanate over a 12 hour dosing interval in paediatric patients in the weight range of 5 to 40 kg receiving Augmentin at 45/3.2 mg/kg orally every 12 hours for up to 10 days.
Phase: Phase 1
Study Indications or Diseases:
  • Infections, Bacterial
Generic Name: amoxicillin/clavulanic acid
Trade/Product Name: augmentin;augmentin
Approved Drug Label: http://www.gsk.com/products.html
Results Summary: Click here to download result summary. Click here to download result summary.
Citations:

The summaries are in PDF format. If you do not have Adobe® Acrobat® Reader™ installed, you can download it for free.